{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T06:54:26Z","timestamp":1781506466354,"version":"3.54.1"},"publisher-location":"New York, NY","reference-count":16,"publisher":"Springer US","isbn-type":[{"value":"9781071648100","type":"print"},{"value":"9781071648117","type":"electronic"}],"license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-4811-7_5","type":"book-chapter","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T01:25:10Z","timestamp":1759281910000},"page":"67-87","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Automated Quantification of Dystrophin Expression by Immunofluorescence in Humans and Animal Models"],"prefix":"10.1007","author":[{"given":"Tatyana A.","family":"Vetter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"Lawlor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"issue":"4","key":"5_CR1","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/0092-8674(88)90065-7","volume":"54","author":"E Bonilla","year":"1988","unstructured":"Bonilla E, Samitt CE, Miranda AF, Hays AP, Salviati G, DiMauro S, Kunkel LM, Hoffman EP, Rowland LP (1988) Duchenne muscular dystrophy: deficiency of dystrophin at the muscle cell surface. Cell 54(4):447\u2013452. https:\/\/doi.org\/10.1016\/0092-8674(88)90065-7","journal-title":"Cell"},{"issue":"6172","key":"5_CR2","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1038\/333466a0","volume":"333","author":"EE Zubrzycka-Gaarn","year":"1988","unstructured":"Zubrzycka-Gaarn EE, Bulman DE, Karpati G, Burghes AH, Belfall B, Klamut HJ, Talbot J, Hodges RS, Ray PN, Worton RG (1988) The Duchenne muscular dystrophy gene product is localized in sarcolemma of human skeletal muscle. Nature 333(6172):466\u2013469. https:\/\/doi.org\/10.1038\/333466a0","journal-title":"Nature"},{"key":"5_CR3","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.omtm.2022.08.009","volume":"27","author":"KM Flanigan","year":"2022","unstructured":"Flanigan KM, Vetter TA, Simmons TR, Iammarino M, Frair EC, Rinaldi F, Chicoine LG, Harris J, Cheatham JP, Cheatham SL, Boe B, Waldrop MA, Zygmunt DA, Packer D, Martin PT (2022) A first-in-human phase I\/IIa gene transfer clinical trial for Duchenne muscular dystrophy using rAAVrh74.MCK.GALGT2. Mol Ther Methods Clin Dev 27:47\u201360. https:\/\/doi.org\/10.1016\/j.omtm.2022.08.009","journal-title":"Mol Ther Methods Clin Dev"},{"key":"5_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtm.2023.101144","volume":"31","author":"LV Gushchina","year":"2023","unstructured":"Gushchina LV, Bradley AJ, Vetter TA, Lay JW, Rohan NL, Frair EC, Wein N, Flanigan KM (2023) Persistence of exon 2 skipping and dystrophin expression at 18 months after U7snRNA-mediated therapy in the Dup2 mouse model. Mol Ther Methods Clin Dev 31:101144. https:\/\/doi.org\/10.1016\/j.omtm.2023.101144","journal-title":"Mol Ther Methods Clin Dev"},{"key":"5_CR5","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.omtn.2022.10.025","volume":"30","author":"LV Gushchina","year":"2022","unstructured":"Gushchina LV, Vetter TA, Frair EC, Bradley AJ, Grounds KM, Lay JW, Huang N, Suhaiba A, Schnell FJ, Hanson G, Simmons TR, Wein N, Flanigan KM (2022) Systemic PPMO-mediated dystrophin expression in the Dup2 mouse model of Duchenne muscular dystrophy. Mol Ther Nucleic Acids 30:479\u2013492. https:\/\/doi.org\/10.1016\/j.omtn.2022.10.025","journal-title":"Mol Ther Nucleic Acids"},{"key":"5_CR6","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.omtm.2021.03.014","volume":"21","author":"TR Simmons","year":"2021","unstructured":"Simmons TR, Vetter TA, Huang N, Vulin-Chaffiol A, Wein N, Flanigan KM (2021) Pre-clinical dose-escalation studies establish a therapeutic range for U7snRNA-mediated DMD exon 2 skipping. Mol Ther Methods Clin Dev 21:325\u2013340. https:\/\/doi.org\/10.1016\/j.omtm.2021.03.014","journal-title":"Mol Ther Methods Clin Dev"},{"key":"5_CR7","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1016\/j.omtm.2023.08.009","volume":"30","author":"AA Stephenson","year":"2023","unstructured":"Stephenson AA, Nicolau S, Vetter TA, Dufresne GP, Frair EC, Sarff JE, Wheeler GL, Kelly BJ, White P, Flanigan KM (2023) CRISPR-Cas9 homology-independent targeted integration of exons 1-19 restores full-length dystrophin in mice. Mol Ther Methods Clin Dev 30:486\u2013499. https:\/\/doi.org\/10.1016\/j.omtm.2023.08.009","journal-title":"Mol Ther Methods Clin Dev"},{"issue":"3","key":"5_CR8","doi-asserted-by":"publisher","DOI":"10.1111\/nan.12785","volume":"48","author":"TA Vetter","year":"2022","unstructured":"Vetter TA, Nicolau S, Bradley AJ, Frair EC, Flanigan KM (2022) Automated immunofluorescence analysis for sensitive and precise dystrophin quantification in muscle biopsies. Neuropathol Appl Neurobiol 48(3):e12785. https:\/\/doi.org\/10.1111\/nan.12785","journal-title":"Neuropathol Appl Neurobiol"},{"key":"5_CR9","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.omtm.2022.07.005","volume":"26","author":"N Wein","year":"2022","unstructured":"Wein N, Vetter TA, Vulin A, Simmons TR, Frair EC, Bradley AJ, Gushchina LV, Almeida CF, Huang N, Lesman D, Rajakumar D, Weiss RB, Flanigan KM (2022) Systemic delivery of an AAV9 exon-skipping vector significantly improves or prevents features of Duchenne muscular dystrophy in the Dup2 mouse. Mol Ther Methods Clin Dev 26:279\u2013293. https:\/\/doi.org\/10.1016\/j.omtm.2022.07.005","journal-title":"Mol Ther Methods Clin Dev"},{"key":"5_CR10","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1111\/j.1365-2990.2009.01056.x","volume":"36","author":"V Arechavala-Gomeza","year":"2010","unstructured":"Arechavala-Gomeza V, Kinali M, Feng L, Brown SC, Sewry C, Morgan JE, Muntoni F (2010) Immunohistological intensity measurements as a tool to assess sarcolemma-associated protein expression. Neuropathol Appl Neurobiol 36:265\u2013274. https:\/\/doi.org\/10.1111\/j.1365-2990.2009.01056.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"5_CR11","doi-asserted-by":"publisher","unstructured":"Beekman C, Sipkens JA, Testerink J, Giannakopoulos S, Kreuger D, Van Deutekom JC, Campion GV, De Kimpe SJ, Lourbakos A (2014) A sensitive, reproducible and objective immunofluorescence analysis method of dystrophin in individual fibers in samples from patients with duchenne muscular dystrophy. PLoS One 9. https:\/\/doi.org\/10.1371\/journal.pone.0107494","DOI":"10.1371\/journal.pone.0107494"},{"key":"5_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0194540","volume":"13","author":"V Sardone","year":"2018","unstructured":"Sardone V, Ellis M, Torelli S, Feng L, Chambers D, Eastwood D, Sewry C, Phadke R, Morgan JE, Muntoni F (2018) A novel high-throughput immunofluorescence analysis method for quantifying dystrophin intensity in entire transverse sections of Duchenne muscular dystrophy muscle biopsy samples. PLoS One 13:1\u201321. https:\/\/doi.org\/10.1371\/journal.pone.0194540","journal-title":"PLoS One"},{"key":"5_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40478-020-00918-5","volume":"8","author":"D Scaglioni","year":"2020","unstructured":"Scaglioni D, Ellis M, Catapano F, Torelli S, Chambers D, Feng L, Sewry C, Morgan J, Muntoni F, Phadke R (2020) A high-throughput digital script for multiplexed immunofluorescent analysis and quantification of sarcolemmal and sarcomeric proteins in muscular dystrophies. Acta Neuropathol Commun 8:1\u201316. https:\/\/doi.org\/10.1186\/s40478-020-00918-5","journal-title":"Acta Neuropathol Commun"},{"key":"5_CR14","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1111\/j.1365-2990.2012.01250.x","volume":"38","author":"LE Taylor","year":"2012","unstructured":"Taylor LE, Kaminoh YJ, Rodesch CK, Flanigan KM (2012) Quantification of dystrophin immunofluorescence in dystrophinopathy muscle specimens. Neuropathol Appl Neurobiol 38:591\u2013601. https:\/\/doi.org\/10.1111\/j.1365-2990.2012.01250.x","journal-title":"Neuropathol Appl Neurobiol"},{"key":"5_CR15","doi-asserted-by":"publisher","unstructured":"Aeffner F, Faelan C, Moore SA, Moody A, Black JC, Charleston JS, Frank DE, Dworzak J, Kris Piper J, Ranjitkar M, Wilson K, Kanaly S, Rudmann DG, Lange H, David Young G, Milici AJ (2019) Validation of a muscle-specific tissue image analysis tool for quantitative assessment of dystrophin staining in frozen muscle biopsies. Arch Pathol Lab Med. https:\/\/doi.org\/10.5858\/arpa.2017-0536-OA","DOI":"10.5858\/arpa.2017-0536-OA"},{"key":"5_CR16","doi-asserted-by":"publisher","first-page":"147","DOI":"10.3233\/JND-180357","volume":"6","author":"A Aartsma-Rus","year":"2019","unstructured":"Aartsma-Rus A, Morgan J, Lonkar P, Neubert H, Owens J, Binks M, Montolio M, Phadke R, Datson N, Van Deutekom J, Morris GE, Rao VA, Hoffman EP, Muntoni F, Arechavala-Gomeza V (2019) Report of a TREAT-NMD\/world duchenne organisation meeting on dystrophin quantification methodology. J Neuromuscul Dis 6:147\u2013159. https:\/\/doi.org\/10.3233\/JND-180357","journal-title":"J Neuromuscul Dis"}],"container-title":["Methods in Molecular Biology","Duchenne Muscular Dystrophy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-4811-7_5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T06:32:52Z","timestamp":1781505172000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-4811-7_5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"ISBN":["9781071648100","9781071648117"],"references-count":16,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-4811-7_5","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]},"assertion":[{"value":"1 October 2025","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}